<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04965168</url>
  </required_header>
  <id_info>
    <org_study_id>691:11/2020</org_study_id>
    <nct_id>NCT04965168</nct_id>
  </id_info>
  <brief_title>Corneal Endothelium Evaluation After Phacoemulsification in Diabetec and Non-diabetic Patients With Pseudoexfoliation</brief_title>
  <official_title>Evaluation of Corneal Endothelium Following Phacoemulsification in Diabetic and Non-diabetic Patients With Pseudoexfoliation Syndrome by Specular Microscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Minia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Minia University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our study is a comparative study, that was conducted to evaluate the corneal endothelial&#xD;
      cells changes and central corneal thickness after uncomplicated phacoemulsification and intra&#xD;
      ocular lens (IOL) implantation in normal controls, in non-diabetic and diabetic patients with&#xD;
      PEX, and in patients with PEX only using specular microscopy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Our study is a comparative study that included 4 groups (controls, patients with PEX,&#xD;
      non-diabetic patients with PEX, diabetic patients with PEX) to evaluate the corneal&#xD;
      endothelial cells changes and central corneal thickness after uncomplicated&#xD;
      phacoemulsification and intra ocular lens (IOL) implantation using specular microscopy, over&#xD;
      a 6 months follow up period.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 1, 2020</start_date>
  <completion_date type="Actual">October 16, 2021</completion_date>
  <primary_completion_date type="Actual">October 12, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>endothelial cell density</measure>
    <time_frame>6 months</time_frame>
    <description>number of endothelial cells</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of hexagonal cells</measure>
    <time_frame>6 months</time_frame>
    <description>indicator of healthy endothelial cells</description>
  </primary_outcome>
  <primary_outcome>
    <measure>coefficient of variation (CV)</measure>
    <time_frame>6 months</time_frame>
    <description>indicator of the uniformity of the size of endothelial cells</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Central corneal thickness</measure>
    <time_frame>6 months</time_frame>
    <description>measurement of the distance between the epithelium and endothelium at the central cornea</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">61</enrollment>
  <condition>Pseudoexfoliation</condition>
  <arm_group>
    <arm_group_label>controls</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>phacoemulsification and IOL implantation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>diabetic without pseudoexfoliation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>phacoemulsification and IOL implantation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non-diabetic with pseudoexfoliation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>phacoemulsification and IOL implantation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>diabetic with pseudoexfoliation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>phacoemulsification and IOL implantation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>phacoemulsification of the lens</intervention_name>
    <description>all patients underwent phacoemulsification and IOL implantation for immature cataract extraction</description>
    <arm_group_label>controls</arm_group_label>
    <arm_group_label>diabetic with pseudoexfoliation</arm_group_label>
    <arm_group_label>diabetic without pseudoexfoliation</arm_group_label>
    <arm_group_label>non-diabetic with pseudoexfoliation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Senile cataract with age between 50 to 70 years&#xD;
&#xD;
          -  Clear cornea with no zonuler dehiscence&#xD;
&#xD;
          -  Lens opacity classification system III (LOCS III), with grade 2-3 nuclear cataract&#xD;
             with any additional cortical (C) and posterior sub capsular (P)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Uncontrolled DM in diabetic groups&#xD;
&#xD;
          -  Presence of autoimmune diseases&#xD;
&#xD;
          -  Patients with glaucoma&#xD;
&#xD;
          -  Corneal guttata&#xD;
&#xD;
          -  Zonular dehiscence&#xD;
&#xD;
          -  Rupture posterior capsule during cataract surgery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Heba R AttaAllah, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty of Medicine, Minia University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ophthalmology department/ Minia University Hospital/Minia University</name>
      <address>
        <city>Minya</city>
        <zip>61111</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Storr-Paulsen A, Singh A, Jeppesen H, Norregaard JC, Thulesen J. Corneal endothelial morphology and central thickness in patients with type II diabetes mellitus. Acta Ophthalmol. 2014 Mar;92(2):158-60. doi: 10.1111/aos.12064. Epub 2013 Feb 7.</citation>
    <PMID>23387877</PMID>
  </reference>
  <reference>
    <citation>Fernández-Muñoz E, Zamora-Ortiz R, Gonzalez-Salinas R. Endothelial cell density changes in diabetic and nondiabetic eyes undergoing phacoemulsification employing phaco-chop technique. Int Ophthalmol. 2019 Aug;39(8):1735-1741. doi: 10.1007/s10792-018-0995-y. Epub 2018 Jul 28.</citation>
    <PMID>30056522</PMID>
  </reference>
  <reference>
    <citation>Oltulu R, Satirtav G, Kayitmazbatir ET, Bitirgen G, Ozkagnici A, Karaibrahimoglu A. Characteristics of the cornea in patients with pseudoexfoliation syndrome. Arq Bras Oftalmol. 2015 Nov-Dec;78(6):348-51. doi: 10.5935/0004-2749.20150092.</citation>
    <PMID>26677035</PMID>
  </reference>
  <reference>
    <citation>Aoki T, Kitazawa K, Inatomi T, Kusada N, Horiuchi N, Takeda K, Yokoi N, Kinoshita S, Sotozono C. Publisher Correction: Risk Factors for Corneal Endothelial Cell Loss in Patients with Pseudoexfoliation Syndrome. Sci Rep. 2020 May 26;10(1):8800. doi: 10.1038/s41598-020-66089-4.</citation>
    <PMID>32451432</PMID>
  </reference>
  <reference>
    <citation>Quiroga L, Lansingh VC, Samudio M, Peña FY, Carter MJ. Characteristics of the corneal endothelium and pseudoexfoliation syndrome in patients with senile cataract. Clin Exp Ophthalmol. 2010 Jul;38(5):449-55. doi: 10.1111/j.1442-9071.2010.02313.x. Epub 2010 Apr 28.</citation>
    <PMID>20456430</PMID>
  </reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>July 7, 2021</study_first_submitted>
  <study_first_submitted_qc>July 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 16, 2021</study_first_posted>
  <last_update_submitted>November 11, 2021</last_update_submitted>
  <last_update_submitted_qc>November 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Minia University</investigator_affiliation>
    <investigator_full_name>Heba Radi AttaAllah</investigator_full_name>
    <investigator_title>Associate Professor of Ophthalmology</investigator_title>
  </responsible_party>
  <keyword>DM</keyword>
  <keyword>phacoemulsification</keyword>
  <keyword>endothelial cell density</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

